RESULTS: The mean warm ischaemia time (WIT) was shorter in the OPN group than in the RAPN group (15.4±5.9 vs 19.2±7.3 min; P < 0.001). Conversely, the median (interquartile range, IQR) estimated blood loss (EBL) was 150 (100-300) mL in the OPN group and 100 (50-150) mL in the RAPN group (P < 0.001). There were no differences in operative time (p=0.18) and the intraoperative complication rate (p=0.31) between the approaches. Postoperative complications were recorded in 43 (21.5%) patients who underwent OPN and in 28 (14%) who received RAPN (p=0.02). Moreover, major complications (grade 3-4) were reported in nine (4.5%) patients after OPN and in nine (4.5%) after RAPN. Positive margins were detected in nine (5.5%) patients after OPN and in nine (5.7%) after RAPN (p=0.98). The mean ±SD 3-month estimated glomerular filtration rate declined by 16.6±18.1 ml/min from preoperative value in the OPN group and by 16.4± 22.9 ml/min in the RAPN group (p=0.28).
CONCLUSIONS: RAPN can achieve equivalent perioperative, early oncological and functional outcomes as OPN. Moreover, RAPN is a less invasive approach, offering a lower risk of bleeding and postoperative complications than OPN.
